Oncology & Cancer
Study compares cancer drug cost, benefit
Queen's University researcher Christopher Booth reveals the price of new cancer therapies is not associated with treatment effectiveness.
Jun 6, 2017
0
0
Lancet Oncology
Oncology & Cancer
Dramatic changes to radiotherapy treatments due to COVID-19
Dramatic changes were seen in the delivery of radiotherapy treatments for cancer during the first wave of the coronavirus pandemic in England.
Jan 23, 2021
0
10
Oncology & Cancer
AI can be used to detect and grade prostate cancer
Researchers at Karolinska Institutet in Sweden and Tampere University in Finland have developed a method based on artificial intelligence (AI) for histopathological diagnosis and grading of prostate cancer. The AI-system ...
Jan 8, 2020
0
85
Oncology & Cancer
Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows. After 30–40 sessions in a hyperbaric chamber, many patients experienced ...
Oct 15, 2019
0
5
Oncology & Cancer
Switching the order of breast cancer treatments may lead to better care
Changing the order of treatments given to breast cancer patients could reduce side effects and improve outcomes, according to an Imperial study.
Jul 28, 2022
0
79
Oncology & Cancer
Research collaboration changes international classification of firefighting to carcinogenic
The International Agency for Research on Cancer (IARC) recently classified occupational exposure as a firefighter as "carcinogenic," changing the previous classification of "possibly carcinogenic." The reclassification came ...
Jul 20, 2022
0
126
Oncology & Cancer
BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma patients whose disease has relapsed or is resistant to other standard ...
Dec 16, 2019
0
44
Oncology & Cancer
Novel therapy may improve survival for patients with malignant gliomas
A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial ...
Jul 30, 2021
0
79
Oncology & Cancer
ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer
HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refractory HER2-positive biliary tract cancer (BTC), researchers from The University of Texas MD Anderson Cancer Center ...
Jun 3, 2023
0
6
Oncology & Cancer
Breast cancer study confirms importance of multigenerational family data to assess risk
A team of researchers led by Columbia University Mailman School of Public Health Professor Mary Beth Terry, Ph.D., evaluated four commonly used breast cancer prediction models and found that family-history-based models perform ...
Feb 21, 2019
0
33
